GFAP and type 2 diabetes mellitus: A case–control/cohort study by Guerro et al. reported that GFAP levels were considerably higher in patients with neurocognitive disorders compared to healthy controls and the highest concentrations were found in individuals with both neurocognitive disorders and type 2 diabetes [36].